| Molecule | Cat. No. | Product Name | Species | Host | Structure | Purity | Activity | Size&Price | Add to Cart |
|---|---|---|---|---|---|---|---|---|---|
| Klotho beta | Human Klotho beta / KLB Protein, His Tag | Human | HEK293 | ![]() | SDS-PAGE | $395.00 100ug | |||
| Klotho beta | Mouse Klotho beta / KLB Protein, His Tag | Mouse | HEK293 | ![]() | SDS-PAGE | $395.00 100ug | |||
| Klotho beta | Cynomolgus / Rhesus macaque Klotho beta Protein, His Tag, low endotoxin (BLI verified) | Cynomolgus / Rhesus macaque | HEK293 | ![]() | SDS-PAGE | $360.00 100ug | |||
| Klotho beta | Biotinylated Human Klotho beta / KLB Protein, His Tag, ultra sensitivity (primary amine labeling) | Human | HEK293 | ![]() | SDS-PAGE | $325.00 25ug | |||
| Klotho beta | Biotinylated Mouse Klotho beta / KLB Protein, His Tag, ultra sensitivity (primary amine labeling) (HPLC verified) | Mouse | HEK293 | ![]() | HPLCSDS-PAGE | $415.00 25ug | |||
| Klotho beta | Rat Klotho beta / KLB Protein, His Tag | Rat | HEK293 | ![]() | SDS-PAGE | $360.00 100ug | |||
| Klotho beta | Biotinylated Rhesus macaque Klotho beta / KLB Protein, His Tag, ultra sensitivity (primary amine labeling) | Rhesus macaque | HEK293 | ![]() | SDS-PAGE | $415.00 25ug |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| NGM-313 | NGM-313; MK-3655 | Phase 2 Clinical | NGM Biopharmaceuticals Inc | Hepatitis; Metabolic Dysfunction-Associated Steatotic Liver Disease; Obesity | Details |
| JMT-202 | JMT202; JMT-202 | Phase 2 Clinical | Shanghai Jmt-Bio Inc | Hypertriglyceridemia | Details |
| DR-10624 | DR-10624; DR10624 | Phase 2 Clinical | Zhejiang Doer Biologics Corp | Diabetes Mellitus; Diabetes Mellitus, Type 2; Hypertriglyceridemia; Metabolic Dysfunction-Associated Steatotic Liver Disease; Metabolic Syndrome; Obesity; Overweight | Details |